161 related articles for article (PubMed ID: 37870166)
1. Fusing Positive and Negative CT Contrast Nanoagent for the Sensitive Detection of Hepatoma.
Meng X; Gao J; Sun Y; Duan F; Chen B; Lv G; Li H; Jiang X; Wu Y; Zhang J; Fang X; Yao Z; Zuo C; Bu W
Adv Sci (Weinh); 2023 Dec; 10(34):e2304668. PubMed ID: 37870166
[TBL] [Abstract][Full Text] [Related]
2. Hepatoma feeding arteriogram created by CT during aortography using IVR 64-multidetector-row CT for catheterization in transcatheter arterial chemoembolization for hepatocellular carcinoma.
Minamiguchi H; Kawai N; Sato M; Ikoma A; Sanda H; Nakata K; Tanaka F; Nakai M; Sonomura T; Murotani K; Hosokawa S; Nishioku T
Jpn J Radiol; 2013 Jun; 31(6):428-36. PubMed ID: 23657922
[TBL] [Abstract][Full Text] [Related]
3. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract][Full Text] [Related]
4. Dynamic computed tomography of isodense hepatocellular carcinoma.
Hosoki T; Toyonaga Y; Araki Y; Mori S
J Comput Assist Tomogr; 1984 Apr; 8(2):263-8. PubMed ID: 6323555
[TBL] [Abstract][Full Text] [Related]
5. Bimodal Molecule as NIR-CT Contrast Agent for Hepatoma Specific Imaging.
Shuai T; Zhou Y; Shao G; Yang R; Wang L; Wang J; Sun J; Ren L; Wang J; Liao Y; Wei M; Xu Q; Li Y; Zhao L
Anal Chem; 2020 Jan; 92(1):1138-1146. PubMed ID: 31820637
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE.
Hu W; Cao G; Ye S; Xu J; Chen J; Shao G
Medicine (Baltimore); 2023 Jun; 102(24):e34054. PubMed ID: 37327303
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
[TBL] [Abstract][Full Text] [Related]
8. Area extraction of the liver and hepatocellular carcinoma in CT scans.
Kim KB; Kim CW; Kim GH
J Digit Imaging; 2008 Oct; 21 Suppl 1(Suppl 1):S89-103. PubMed ID: 17846836
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
[TBL] [Abstract][Full Text] [Related]
10. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
[TBL] [Abstract][Full Text] [Related]
11. Poor detection of a hepatoma with a hepatic specific contrast agent (EOE 13).
Witrak BJ; Bernardino ME
J Comput Assist Tomogr; 1983 Oct; 7(5):905-7. PubMed ID: 6309930
[TBL] [Abstract][Full Text] [Related]
12. CT of retroperitoneal extension of hepatoma mimicking adrenal tumor.
Kim KW; Auh YH; Chi HS; Lee SI
J Comput Assist Tomogr; 1993; 17(4):599-602. PubMed ID: 8392525
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography of hepatocellular carcinoma.
Kunstlinger F; Federle MP; Moss AA; Marks W
AJR Am J Roentgenol; 1980 Mar; 134(3):431-7. PubMed ID: 6243845
[TBL] [Abstract][Full Text] [Related]
14. CT Radiomics in Oncology: Insights into the Tumor Microenvironment of Hepatocellular Carcinoma.
Yoon JH; Kim H
Radiology; 2023 Apr; 307(1):e222988. PubMed ID: 36511812
[No Abstract] [Full Text] [Related]
15. Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma.
Hennedige T; Yang ZJ; Ong CK; Venkatesh SK
Abdom Imaging; 2014 Dec; 39(6):1247-54. PubMed ID: 24943135
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
[TBL] [Abstract][Full Text] [Related]
17. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
[TBL] [Abstract][Full Text] [Related]
18. Use of meglumine iotroxate in the detection of liver tumors by computed tomography.
Hosoki T; Mori S
Comput Radiol; 1985; 9(6):387-93. PubMed ID: 3004809
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
20. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
